Pro Share Advisors LLC Fate Therapeutics Inc Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 18,917 shares of FATE stock, worth $31,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,917

Previous 11,351 66.65%

Holding current value

$31,402

Previous $37,000 78.38%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.12 - $5.57 $23,605 - $42,142	7,566 Added 66.65%	18,917 $66,000
Q2 2024 Aug 13, 2024	SELL	$3.26 - $7.08 $12,635 - $27,442	-3,876 Reduced 25.45%	11,351 $37,000
Q1 2024 May 08, 2024	BUY	$3.54 - $8.35 $4,244 - $10,011	1,199 Added 8.55%	15,227 $111,000
Q4 2023 Feb 14, 2024	SELL	$1.65 - $3.94 $5,649 - $13,490	-3,424 Reduced 19.62%	14,028 $52,000
Q3 2023 Nov 13, 2023	BUY	$2.02 - $5.04 $127 - $317	63 Added 0.36%	17,452 $36,000
Q2 2023 Aug 10, 2023	BUY	$4.76 - $6.59 $3,808 - $5,272	800 Added 4.82%	17,389 $82,000
Q1 2023 May 11, 2023	SELL	$4.24 - $11.12 $14,390 - $37,741	-3,394 Reduced 16.98%	16,589 $94,000
Q4 2022 Feb 02, 2023	BUY	$9.86 - $23.83 $13,281 - $32,099	1,347 Added 7.23%	19,983 $201,000
Q3 2022 Nov 04, 2022	BUY	$21.04 - $36.06 $8,984 - $15,397	427 Added 2.34%	18,636 $418,000
Q2 2022 Aug 01, 2022	SELL	$17.78 - $42.39 $157,246 - $374,897	-8,844 Reduced 32.69%	18,209 $450,000
Q1 2022 May 10, 2022	SELL	$29.67 - $60.28 $182,618 - $371,023	-6,155 Reduced 18.53%	27,053 $1.05 Million
Q4 2021 Feb 08, 2022	BUY	$47.84 - $64.34 $26,886 - $36,159	562 Added 1.72%	33,208 $1.94 Million
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $297,298 - $480,181	-5,016 Reduced 13.32%	32,646 $1.94 Million
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $293,210 - $403,387	4,360 Added 13.09%	37,662 $3.27 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $286,403 - $465,960	3,969 Added 13.53%	33,302 $2.75 Million
Q4 2020 Feb 09, 2021	BUY	$38.09 - $100.95 $249,832 - $662,131	6,559 Added 28.8%	29,333 $2.67 Million
Q3 2020 Nov 13, 2020	BUY	$30.41 - $40.5 $56,136 - $74,763	1,846 Added 8.82%	22,774 $910,000
Q2 2020 Aug 03, 2020	BUY	$20.21 - $35.23 $140,944 - $245,694	6,974 Added 49.98%	20,928 $718,000
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $183,427 - $338,406	-10,615 Reduced 43.2%	13,954 $310,000
Q4 2019 Feb 12, 2020	BUY	$13.39 - $20.73 $12,613 - $19,527	942 Added 3.99%	24,569 $481,000
Q3 2019 Nov 12, 2019	SELL	$15.47 - $22.5 $28,186 - $40,995	-1,822 Reduced 7.16%	23,627 $367,000
Q2 2019 Aug 13, 2019	SELL	$15.61 - $20.44 $47,829 - $62,628	-3,064 Reduced 10.75%	25,449 $517,000
Q1 2019 May 15, 2019	BUY	$13.15 - $18.71 $3,195 - $4,546	243 Added 0.86%	28,513 $501,000
Q4 2018 Feb 14, 2019	BUY	$11.48 - $16.98 $324,539 - $480,024	28,270 New	28,270 $363,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $161M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Fate Therapeutics Inc Transaction History